Medifast (NYSE:MED) Director Scott Schlackman Purchases 2,500 Shares of Stock

Medifast Inc (NYSE:MED) Director Scott Schlackman purchased 2,500 shares of the stock in a transaction that occurred on Friday, May 8th. The stock was purchased at an average price of $12.65 per share, with a total value of $31,625.00. Following the acquisition, the director directly owned 28,049 shares of the company’s stock, valued at $354,819.85. This trade represents a 9.79% increase in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.

Scott Schlackman also recently made the following trade(s):

• On Monday, May 11th, Scott Schlackman acquired 2,500 shares of Medifast stock. The stock was purchased at an average price of $12.53 per share, with a total value of $31,325.00.

Medifast Stock Performance

Shares of MED opened at $12.56 on Wednesday. The company has a 50 day moving average price of $10.66 and a 200-day moving average price of $11.09. Medifast Inc has a fifty-two week low of $9.22 and a fifty-two week high of $15.46. The stock has a market capitalization of $139.62 million, a PE ratio of -6.86 and a beta of 0.55.

Medifast (NYSE:MED) last posted its earnings results on Monday, May 4th. The specialty retailer reported ($0.19) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.55) by $0.36. Medifast had a negative return on equity of 4.80% and a negative net margin of 5.78%.The company had revenue of $76.04 million for the quarter, compared to analyst estimates of $69.20 million. Medifast has set its FY 2026 guidance at -2.750–1.550 EPS and its Q2 2026 guidance at -1.000–0.500 EPS. Equities research analysts forecast that Medifast Inc will post -2 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently added to or reduced their stakes in the business. Dimensional Fund Advisors LP lifted its position in Medifast by 10.9% during the 1st quarter. Dimensional Fund Advisors LP now owns 361,762 shares of the specialty retailer’s stock worth $3,686,000 after buying an additional 35,522 shares in the last quarter. Corient Private Wealth LLC acquired a new position in Medifast during the 4th quarter valued at about $139,000. Empowered Funds LLC boosted its stake in shares of Medifast by 11.1% in the 4th quarter. Empowered Funds LLC now owns 44,773 shares of the specialty retailer’s stock valued at $478,000 after purchasing an additional 4,462 shares during the last quarter. Man Group plc grew its position in shares of Medifast by 10.8% during the 4th quarter. Man Group plc now owns 236,500 shares of the specialty retailer’s stock worth $2,526,000 after buying an additional 23,070 shares during the period. Finally, Trexquant Investment LP lifted its holdings in Medifast by 88.0% in the fourth quarter. Trexquant Investment LP now owns 126,959 shares of the specialty retailer’s stock valued at $1,356,000 after buying an additional 59,439 shares during the period. Institutional investors and hedge funds own 95.51% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently weighed in on MED. Weiss Ratings cut Medifast from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded Medifast from a “sell” rating to a “hold” rating in a research report on Saturday, March 21st. Finally, Stephens lowered their price target on shares of Medifast from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Thursday, February 19th. One equities research analyst has rated the stock with a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Medifast presently has an average rating of “Reduce” and a consensus target price of $12.00.

About Medifast

Medifast, Inc (NYSE: MED) is a health and wellness company specializing in clinically supported weight-loss, weight-management and healthy living products and services. Through its OPTAVIA brand, the company offers a range of meal replacement products, snacks, supplements and coaching programs designed to support metabolic health and sustainable lifestyle changes. Medifast markets its products directly to consumers via a network of independent distributors—known as OPTAVIA Coaches—who provide personalized guidance and support throughout the client’s weight?loss journey.

Founded in 1980 by William Vitale and headquartered in Baltimore, Maryland, Medifast has grown into a nationally recognized provider of nutrition and weight?management solutions.